Citation

  • Authors: Luo, F., Liu, H., Yang, S., Fang, Y., Zhao, Z., Hu, Y., Jin, Y., Li, P., Gao, T., Cao, C., Liu, X.
  • Year: 2019
  • Journal: J Immunol 202 2254-2265
  • Applications: in vivo / siRNA / in vivo-jetPEI

Method

Wild-type mice treated with negative control siRNA (n = 10) or c-Abl/Arg siRNA (33 mg/mouse) (n = 10) by i.p. injection were injected s.c. with Ft LVS (2 3 105 CFU). The survival of mice was monitored over a 10-d period.

Abstract

The nonreceptor tyrosine kinase c-Abl plays important roles in T cell development and immune responses; however, the mechanism is poorly understood. IFN regulatory factor 3 (IRF3) is a key transcriptional regulator of type I IFN-dependent immune responses against DNA and RNA viruses. The data in this study show that IRF3 is physically associated with c-Abl in vivo and directly binds to c-Abl in vitro. IRF3 is phosphorylated by c-Abl and c-Abl-related kinase, Arg, mainly at Y292. The inhibitor AMN107 inhibits IFN-beta production induced by poly(dA:dT), poly(I:C), and Sendai virus in THP-1 and mouse bone marrow-derived macrophage cells. IRF3-induced transcription of IFN-beta is significantly reduced by the mutation of Y292 to F. Moreover, AMN107 suppresses gene expression of absent in melanoma 2 (AIM2) and subsequently reduces inflammasome activation induced by cytosolic bacteria, dsDNA, and DNA viruses. Consistent with this finding, Francisella tularensis subsp. holarctica live vaccine strain (Ft LVS), which is known as an activator of AIM2 inflammasome, induces death in significantly more C57BL/6 mice treated with the Abl inhibitor AMN107 or c-Abl/Arg small interfering RNA than in untreated mice. This study provides new insight into the function of c-Abl and Arg in regulating immune responses and AIM2 inflammasome activation, especially against Ft LVS infection.

Go to